financetom
Business
financetom
/
Business
/
Johnson Controls International Insider Sold Shares Worth $10,292,167, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Johnson Controls International Insider Sold Shares Worth $10,292,167, According to a Recent SEC Filing
Dec 11, 2024 1:35 AM

03:42 AM EST, 12/11/2024 (MT Newswires) -- George Oliver, Chairman & Chief Executive Officer, on December 10, 2024, sold 124,497 shares in Johnson Controls International ( JCI ) for $10,292,167. Following the Form 4 filing with the SEC, Oliver has control over a total of 1,337,582 shares of the company, with 1,267,716 shares held directly and 69,866 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/833444/000112760224028981/xslF345X05/form4.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Thyssenkrupp assessing Carlyle's bid for marine unit
Thyssenkrupp assessing Carlyle's bid for marine unit
Mar 19, 2024
(Reuters) -Thyssenkrupp on Tuesday said it is evaluating the potential partial sale of its marine unit to investment firm Carlyle. With the active involvement of Carlyle, we are now taking the necessary next step and starting the phase of an open-ended assessment of the relevant business activities, Thyssenkrupp's Executive Board member Volkmar Dinstuhl said in a statement. The German industrial...
Tipping point for low-carbon buildings demand in sight, report says
Tipping point for low-carbon buildings demand in sight, report says
Mar 19, 2024
LONDON, March 19 (Reuters) - Demand for environmentally friendly buildings is set to increase strongly over the next two years as companies with emissions reduction commitments see their leases come up for renewal and seek a greener alternative, real estate company JLL said. WHY IT'S IMPORTANT As more companies commit to reach net-zero emissions by 2050, most will be looking...
AstraZeneca bets on new cancer treatments with $2 billion Fusion Pharma purchase
AstraZeneca bets on new cancer treatments with $2 billion Fusion Pharma purchase
Mar 19, 2024
By Yadarisa Shabong (Reuters) -AstraZeneca ( AZN ) said on Tuesday it will buy clinical-stage biopharmaceutical company Fusion Pharmaceuticals Inc ( FUSN ) for about $2 billion in cash as the Anglo-Swedish drugmaker bets on next-generation cancer treatments. The deal is AstraZeneca's ( AZN ) second this month after it agreed last week to buy Amolyt Pharma for $1.05 billion...
AstraZeneca bets on new cancer treatments with $2 bln Fusion Pharma purchase
AstraZeneca bets on new cancer treatments with $2 bln Fusion Pharma purchase
Mar 19, 2024
By Yadarisa Shabong March 19 (Reuters) - AstraZeneca ( AZN ) said on Tuesday it will buy clinical-stage biopharmaceutical company Fusion Pharmaceuticals Inc ( FUSN ) for about $2 billion in cash as the Anglo-Swedish drugmaker bets on next-generation cancer treatments. The deal is AstraZeneca's ( AZN ) second this month after it agreed last week to buy Amolyt Pharma...
Copyright 2023-2026 - www.financetom.com All Rights Reserved